← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

▼ SELL

$ Value

$6.1M

Shares

337,915

Price

$18

Filed

May 12

Insider

Name

Sabag Mark

Title

See "Remarks"

CIK

0001721442

Roles

Officer

Transaction Details

Transaction Date

2025-05-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

150,996

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.865 to $18.265, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0000950170-25-069132

Form Type

4

Issuer CIK

0000818686

Sabag Mark's History

Date Ticker Type Value
2026-03-05 TEVA M
2026-03-05 TEVA M $0
2026-03-04 TEVA M
2026-03-04 TEVA M
2026-03-04 TEVA M $0
2026-03-04 TEVA M $0
2026-03-04 TEVA A $0
2026-03-03 TEVA M
2026-03-03 TEVA M
2026-03-03 TEVA M $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05